FiercePharma16h
Fierce Pharma Asia—Astellas' investment focus; Mitsubishi Tanabe's buyout; Leqembi's 'expansion phase'
Astellas is shifting its investment focus toward more established modalities and later-stage opportunities, its chief ...
JD Supra14h
Global M&A Trends: Spotlight on Japan
According to a recent KPMG report, the global M&A landscape in 2024 signals a rebound despite challenges like geopolitical tensions, high ...
ENDPOINTS NEWS14h
How Bain’s $3.3B deal for cen­turies-old Tan­abe Phar­ma came to fruition
About two and a half years before they sealed a $3.3 billion deal, Bain Capital and its life sciences team started courting ...
India Infoline14h
Natco Pharma Ltd Summary
Shipments to customers have commenced.On 4 November 2017, Natco Pharma announced that it has executed definitive agreement and subscribed to 7.50% of the paid-up equity share capital of OMRV ...
Indiatimes8h
Natco Pharma Share Price
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 17,464.11 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...
Indiatimes9h
Mankind Pharma Share Price
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,03,189.17 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...